ClinicalTrials.gg
Not yet recruitingNCT07506434Updated Apr 1, 2026

Tourniquet Vs. No-Tourniquet Technique in Total Knee Arthroplasty at the University Hospital of the West Indies

An interventional study of pneumatic tourniquet in Knee Osteoarthritis (OA) and Total Knee Anthroplasty, sponsored by The University of The West Indies. Not yet recruiting at 1 site in Jamaica. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-01.

Sponsored by The University of The West Indies · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to determine whether performing total knee replacement surgery (total knee arthroplasty, TKA) without a tourniquet is clinically equivalent to performing the procedure with a tourniquet in adults with symptomatic knee osteoarthritis.

A tourniquet is commonly used during surgery to reduce bleeding and improve the surgeon's view. However, some studies suggest it may be associated with certain complications. It is currently unclear whether using a tourniquet meaningfully changes outcomes compared to not using one. This study aims to assess whether both approaches result in similar outcomes within a clinically acceptable range.

The main question this study aims to answer is:

Is total blood loss during surgery equivalent between TKA performed with a tourniquet and TKA performed without a tourniquet, within a predefined margin of ±100 mL?

Additional questions include:

Are surgical field quality, postoperative pain, functional recovery, and complication rates comparable between the two techniques?

Researchers will compare:

TKA performed with a pneumatic tourniquet TKA performed without a tourniquet

to determine whether outcomes between the two approaches are equivalent rather than whether one is superior to the other.

Participants will:

Be randomly assigned to one of the two surgical groups using a computer-generated process Undergo standard total knee replacement surgery and routine perioperative care Have blood loss assessed during and after surgery Be monitored for pain, recovery of function, wound healing, and complications during hospital stay and follow-up visits

This study is designed as a randomized controlled equivalence trial to determine whether both surgical approaches produce comparable outcomes within clinically acceptable limits, in a standardized local setting.

02

Conditions studied

  • Knee Osteoarthritis (OA)
  • Total Knee Anthroplasty

Keywords

  • tourniquet use
03

In context

Osteoarthritis, Knee

3,292 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's planned enrollment of 30 is below the median of 68 across 2,714 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

The University of The West Indies is the lead sponsor of 64 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Age ≥ 18 years.

      • Clinical and radiographic diagnosis of knee osteoarthritis requiring primary unilateral Total Knee Arthroplasty.
      • Medically fit for elective surgery (typically ).
      • Able to provide .

Exclusion criteria

Exclusion Criteria:

    • Revision TKA or bilateral simultaneous TKA.

      • Preexisting coagulopathy or active anticoagulation that cannot be perioperatively managed per protocol.
      • Known allergy or to tranexamic acid.
      • Active infection or .
      • Severe peripheral vascular disease in the operative limb.
      • > 45 kg/m²
      • Inability to provide or comply with follow-up
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Tourniquet Group

    Total knee arthroplasty performed with the use of a pneumatic tourniquet throughout the entire procedure

    Device: pneumatic tourniquet

  • No intervention
    No-Tourniquet Group

    Total knee arthroplasty performed without the use of a pneumatic tourniquet

Interventions

  • Devicepneumatic tourniquet

    the use of a pneumatic tourniquet throughout the entire total knee replacement procedure

06

What researchers measure

Primary outcomes

  1. Total perioperative blood loss

    Calculated using the Haemoglobin Balance method

    Time frame: Hb values (pre- and postoperative day 3) will be measured

Secondary outcomes

  1. Bone-cement interface quality

    Standardized digital photographs will be taken at approximately 30 cm from the operating field, using the same camera, technique, and exposure settings for all cases. The quality of the bloodless surgical field on the tibial and femoral cutting surfaces will then be evaluated. The tibial cutting surface will be divided into four equal sections (25% each) and the femoral cutting surface into eight equal sections (12.5% each). A bloodless surgical field will be defined as the absence of visible bloodstain on the cancellous bone surfaces. Two independent physicians, blinded to the intervention and not involved in the surgery, will grade the images. Discrepancies between assessors will be resolved by consensus or adjudicated by a third blinded reviewer.

    Time frame: Taken Intraoperatively

  2. Postoperative pain

    Instrument: Visual Analog Scale (VAS, 10 cm line; score 0-100). Personnel: Research coordinator or ward nurse (blinded to allocation) will administer and record scores

    Time frame: Patients will be asked to mark their pain level at 24 and 48 hours postoperatively.

  3. Knee range of motion

    Instrument: Universal goniometer.

    Time frame: Measured at postoperative day 2 and 6 weeks by a physiotherapist blinded to group allocation.

  4. Knee Injury and Osteoarthritis Outcomes Score for Joint Replacement (KOOS JR) Survey score

    Instrument: Standardized questionnaire Scored as raw sum (0-28) and converted to 0-100 interval scale (higher = better function)

    Time frame: Administered at postoperative day 2 and 6 weeks by the research coordinator.

  5. Perioperative complications

    Measured outcomes: i. Perioperative transfusion rates (from transfusion records) ii. Tourniquet-related complications (wound seepage, infection, subcutaneous hematoma/ecchymosis, tension blisters), to be assessed during ward rounds and recorded by blinded surgical team members. iii. Thromboembolic events - confirmed via venous Doppler ultrasound or CT pulmonary angiogram as clinically indicated. iv. Wound complications (infection, delayed healing) - assessed at follow-up visits by blinded clinic staff. v. Neurovascular injury - documented by clinical exam postoperatively.

    Time frame: Recorded up to 6 weeks postoperatively

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07506434
Lead sponsor
The University of The West Indies
Responsible party
Sponsor
First posted
Apr 1, 2026
Start date
Jun 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Apr 1, 2026

Study contacts

Dominic Landell, MBBS
Contact
d.landell@hotmail.com
+18763257551
Maxim Christmas, DM (Orthopaedics), FACS, FCCS
principal investigator · University of the West Indies, Mona Campus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion